Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2026-02-23 @ 8:33 AM
Study NCT ID:
NCT03000257
Status:
COMPLETED
Last Update Posted:
2022-04-14
First Post:
2016-12-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors
Sponsor:
AbbVie
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Solid Tumors | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Budigalimab | View |
| None | Cancer | View |
| None | Advanced Solid Tumors | View |
| None | Non-small cell lung cancer (NSCLC) | View |
| None | Triple negative breast cancer | View |
| None | Ovarian cancer | View |
| None | Hepatocellular carcinoma | View |
| None | Gastric cancer | View |
| None | Small cell lung cancer | View |
| None | Mesothelioma | View |
| None | Cholangiocarcinoma | View |
| None | Merkel cell carcinoma | View |
| None | Head and neck cancer | View |